Literature DB >> 7357747

Immunoreactive nervous system of specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid.

K W Brown, P A Kynoch, R J Thompson.   

Abstract

Nervous system-specific 14-3-2 protein is an acidic enolase (EC 4.2.1.11) isoenzyme which is found in high concentrations in nervous tissue and which is also considered to be a molecular marker for amine precursor uptake and decarboxylation (APUD) cells. A radioimmunoassay for this protein shows levels of immunoreactivity of 10 ng/ml and 5 ng/ml in human cerebrospinal fluid and serum respectively. The immunoreactivity in concentrated cerebrospinal fluid dilutes out in parallel with the standard curve in the assay, has a similar molecular weight to the immunoreactivity in soluble protein extracts of whole human brain, and on polyacrylamide gel electrophoresis migrates as two forms representing the homodimer and probably the heterodimer species of the enzyme. The protein also occurs at relatively high levels in erythrocytes and an approximately 1% haemolysis would be sufficient to account for the normal serum level of immunoreactivity. Clinical measurements of 14-3-2 protein in neurological disorders or APUD-system disease could be potentially useful in cerebrospinal fluid but are unlikely to be of value in serum.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357747     DOI: 10.1016/0009-8981(80)90251-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  S100 protein content of umbilical cord blood in healthy newborns in relation to mode of delivery.

Authors:  J W Wirds; A E J Duyn; S D Geraerts; E Preijer; J A A M Van Diemen-Steenvoorde; J H Schagen Van Leeuwen; F J L M Haas; W B M Gerritsen; A De Boer; J A Leusink
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-01       Impact factor: 5.747

Review 2.  Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?

Authors:  Nenad Vasic; Bernhard J Connemann; Robert C Wolf; Hayrettin Tumani; Johannes Brettschneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-12-16       Impact factor: 5.270

3.  Pre- and post-operative changes in serum immunoglobulin level in neurosurgical patients.

Authors:  P A Seeldrayers; N R Hoyle; D G Thomas
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

4.  An ultramicro bioluminescence assay of enolase: application to human cerebrospinal fluid.

Authors:  J L Viallard; M R Murthy; B Dastugue
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

5.  Concentration of neuron-specific enolase and S100 protein in the subretinal fluid of rhegmatogenous retinal detachment.

Authors:  J C Quintyn; F Pereira; M F Hellot; G Brasseur; A Coquerel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-05-20       Impact factor: 3.117

6.  Neuron specific enolase in asphyxiated newborns: association with encephalopathy and cerebral function monitor trace.

Authors:  E Thornberg; K Thiringer; H Hagberg; I Kjellmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-01       Impact factor: 5.747

7.  Neonatal acute megakaryoblastic leukemia mimicking congenital neuroblastoma.

Authors:  Yukako Kawasaki; Masami Makimoto; Keiko Nomura; Akihiro Hoshino; Takeru Hamashima; Mitsuteru Hiwatari; Atsuko Nakazawa; Junko Takita; Taketoshi Yoshida; Hirokazu Kanegane
Journal:  Clin Case Rep       Date:  2014-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.